State-of-the-art biomarker toolkit
0 SAR
Checkout
Overview
Dr. Fortea and Prof. Shi give an overview of AD biomarkers and the specific role ofPET and CSF in the diagnostic toolkit.
This Class for
- Physician
- Resident / Fellow
What I will learn?
- Identify the different toolkits to diagnose Alzheimer's Disease.
Disclaimer
This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
(This information/content is intended to Health Care Providers only)
For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
24 /7 mobile : +966 567 868 843 working hours: +966 11 461 7800 , Ext: 1
For Lilly product information: email: SAUDI_MEDINFOQUERIES@lilly.com
For further information, please contact:
Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: Saudi_Pharmacovigilance@lilly.com
PP-AD-SA-0061
Related Classes
- Communication with patients with Alzheimer`s Disease 3
- Communication with patients with Alzheimer`s Disease 6
- Communication with patients with Alzheimer`s Disease 5
- Communication with patients with Alzheimer`s Disease 4
- Communication with patients with Alzheimer`s Disease 2
- Communication with patients with Alzheimer`s Disease 1
- Barriers and benefits to a timely diagnosis
- Tracking the pathology of Alzheimer's disease